OBJECTIVE: To define the type of orgasmic dysfunction in men after radical prostatectomy (RP), as absence of orgasm and orgasmic pain are recognized complaints, and changes in orgasm may lead to significant sexual dissatisfaction. PATIENTS AND METHODS: Using an unvalidated questionnaire, demographic, erectile function and orgasmic function questions were answered by 239 patients who had previously undergone a retropubic RP. RESULTS: Of the 239 patients, 22% had no change in orgasm intensity, 37% reported a complete absence of orgasm, 37% had decreased orgasm intensity and 4% reported a more intense orgasm after RP than before. Pain during orgasm (dysorgasmia) occurred in 14% of the patients; in these respondents the pain reportedly occurred always (with every orgasm) in 33%, frequently in 13%, occasionally in 35%, and rarely in 19%. Most patients (55%) had orgasm-associated pain for <1 min. CONCLUSIONS: These results indicate that orgasmic functional changes are relatively common after RP and are worth considering by clinicians and researchers.
OBJECTIVE: To define the type of orgasmic dysfunction in men after radical prostatectomy (RP), as absence of orgasm and orgasmic pain are recognized complaints, and changes in orgasm may lead to significant sexual dissatisfaction. PATIENTS AND METHODS: Using an unvalidated questionnaire, demographic, erectile function and orgasmic function questions were answered by 239 patients who had previously undergone a retropubic RP. RESULTS: Of the 239 patients, 22% had no change in orgasm intensity, 37% reported a complete absence of orgasm, 37% had decreased orgasm intensity and 4% reported a more intense orgasm after RP than before. Pain during orgasm (dysorgasmia) occurred in 14% of the patients; in these respondents the pain reportedly occurred always (with every orgasm) in 33%, frequently in 13%, occasionally in 35%, and rarely in 19%. Most patients (55%) had orgasm-associated pain for <1 min. CONCLUSIONS: These results indicate that orgasmic functional changes are relatively common after RP and are worth considering by clinicians and researchers.
Authors: Leslie R Schover; Andrea L Canada; Ying Yuan; Dawen Sui; Leah Neese; Rosell Jenkins; Michelle M Rhodes Journal: Cancer Date: 2011-09-26 Impact factor: 6.860
Authors: Carolyn A Salter; Phil Vu Bach; Eduardo Miranda; Lawrence C Jenkins; Nicole Benfante; Elizabeth Schofield; Christian J Nelson; John P Mulhall Journal: J Sex Med Date: 2020-01-21 Impact factor: 3.802
Authors: Alexander B Nolsøe; Christian Fuglesang S Jensen; Peter B Østergren; Mikkel Fode Journal: Int J Impot Res Date: 2020-12-14 Impact factor: 2.896
Authors: Ioannis Mykoniatis; Koenraad van Renterghem; Ioannis Sokolakis; Georgios Hatzichristodoulou; Maxime Sempels; Robert Andrianne Journal: Int J Impot Res Date: 2020-03-17 Impact factor: 2.896
Authors: Raymond A Clarke; Horst J Schirra; James W Catto; Martin F Lavin; Robert A Gardiner Journal: Cancers (Basel) Date: 2010-06-04 Impact factor: 6.639
Authors: Leslie R Schover; Marleen van der Kaaij; Eleonora van Dorst; Carien Creutzberg; Eric Huyghe; Cecilie E Kiserud Journal: EJC Suppl Date: 2014-05-29